The Impact of HCV eradication on HBAIC in Genotype 3 Chronic HCV Diabetic Patients Authors
Pakistan journal of Gastroenterology · 2025
DOI: 10.63521/pjg.41.3.2025.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pakistan journal of Gastroenterology, 2025. Verfasst von Taha Tariq und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
Hepatitis C Virus (HCV) is a global health concern. WHO estimated that it affects a 170 million people worldwide. In Pakistan, 6.8% of adult population exhibits presence of active disease. With the rise of DAAs especially Sofosbuvir and Velpatasvir the ETR and SVR is remarkable. Patients who secure seroconversion following DAA treatment experience a drop in their HOMA-IR levels, in contrast to those who don't. It means that there are metabolic benefits of HCV eradication. Based on this hypothesis we evaluated the benefit on HBAIC in patients achieving ETR.
Methods
The study sample comprised of 100 type 2 diabetics who attended Gastroenterology clinic at GTTH, a tertiary care hospital in Lahore for treatment of HCV infection. All the confirmed type 2 diabetes cases on any therapy were included in the study sample. Data was analyzed using SPSS Statistics version 24.
Results
Out of study sample of 100 patients, 100% achieved an end of treatment response (ETR). In our study, mean difference in fasting blood sugar (FBS) from baseline to ETR was found to be a decrease of 48.70 ± 22.20mg/dL (p Value
Zitieren
APA
Tariq, T., Waheed, A., Akram, U., & Hayat, U. (2025). The Impact of HCV eradication on HBAIC in Genotype 3 Chronic HCV Diabetic Patients Authors. Pakistan journal of Gastroenterology. https://doi.org/10.63521/pjg.41.3.2025.7
Vancouver
Tariq T, Waheed A, Akram U, Hayat U. The Impact of HCV eradication on HBAIC in Genotype 3 Chronic HCV Diabetic Patients Authors. Pakistan journal of Gastroenterology. 2025. doi:10.63521/pjg.41.3.2025.7
BibTeX
@article{Tariq2025,
author = {Tariq, Taha and Waheed, Ayesha and Akram, Usman and Hayat, Umer},
title = {The Impact of HCV eradication on HBAIC in Genotype 3 Chronic HCV Diabetic Patients Authors},
journal = {Pakistan journal of Gastroenterology},
year = {2025},
doi = {10.63521/pjg.41.3.2025.7}
}
EUVIMED